Clinical Trials
Genoskin launches the ISR platform: the first human skin...
Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical trials....
Clinical Trials
UPS Healthcare Partners with THREAD to Deliver First Decentralized...
UPS Healthcare's clinical trial logistics unit, Marken, and THREAD, an innovative decentralized clinical trial technology provider, announced a partnership to bring the first ever, unified,...
Clinical Trials
Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar...
Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04,...
Clinical Trials
Zydus applies to the DCGI for EUA to launch...
Zydus Cadila announced that the company has applied for EUA to the office of Drug Controller General of India (DCGI) for ZyCoV-D -its Plasmid DNA...
Clinical Trials
Bharat Biotech concludes final analysis for Covaxin efficacy from...
Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole...
Clinical Trials
Positive New Data for Johnson & Johnson Single-Shot COVID-19...
Johnson & Johnson announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent...
Clinical Trials
Mixed Oxford/Pfizer vaccine schedules generate robust immune response against...
Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.
In a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.